Biomea Shares Owned by Institutions

BMEA Stock  USD 15.12  0.00  0.00%   
Biomea Fusion fundamentals help investors to digest information that contributes to Biomea Fusion's financial success or failures. It also enables traders to predict the movement of Biomea Stock. The fundamental analysis module provides a way to measure Biomea Fusion's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Biomea Fusion stock.
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Biomea Shares Owned by Institutions Analysis

Biomea Fusion's Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.
Shares Held by Institutions 
Funds and Banks 
More About Shares Owned by Institutions | All Equity Analysis

Current Biomea Fusion Shares Owned by Institutions

  50.15 %  
Most of Biomea Fusion's fundamental indicators, such as Shares Owned by Institutions, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Biomea Fusion is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Biomea Shares Owned by Institutions Driver Correlations

Understanding the fundamental principles of building solid financial models for Biomea Fusion is extremely important. It helps to project a fair market value of Ford stock properly, considering its historical fundamentals such as Shares Owned by Institutions. Since Biomea Fusion's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Biomea Fusion's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Biomea Fusion's interrelated accounts and indicators.
Since Institution investors conduct a lot of independent research they tend to be more involved and usually more knowledgeable about entities they invest as compared to amateur investors.

Based on the latest financial disclosure, 50% of Biomea Fusion are shares owned by institutions. This is 12.34% higher than that of the Healthcare sector and 5.58% higher than that of the Biotechnology industry. The shares owned by institutions for all United States stocks is 27.9% lower than that of the firm.

Biomea Shares Owned by Institutions Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Biomea Fusion's direct or indirect competition against its Shares Owned by Institutions to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Biomea Fusion could also be used in its relative valuation, which is a method of valuing Biomea Fusion by comparing valuation metrics of similar companies.
Biomea Fusion is currently under evaluation in shares owned by institutions category among related companies.

Biomea Fundamentals

About Biomea Fusion Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Biomea Fusion's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biomea Fusion using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biomea Fusion based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. The company was incorporated in 2017 and is headquartered in Redwood City, California. Biomea Fusion operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 72 people.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Biomea Fusion in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Biomea Fusion's short interest history, or implied volatility extrapolated from Biomea Fusion options trading.

Pair Trading with Biomea Fusion

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Biomea Fusion position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biomea Fusion will appreciate offsetting losses from the drop in the long position's value.

Moving together with Biomea Fusion

+0.69DMACDiaMedica Therapeutics Earnings Call This WeekPairCorr

Moving against Biomea Fusion

-0.81VALNValneva SE ADR Earnings Call TodayPairCorr
-0.75EQEquillium Earnings Call TodayPairCorr
-0.67DNLIDenali Therapeutics Fiscal Quarter End 31st of March 2023 PairCorr
-0.62DICEDice Molecules Holdings Fiscal Quarter End 31st of March 2023 PairCorr
-0.58MBRXMoleculin Biotech Financial Report 10th of May 2023 PairCorr
The ability to find closely correlated positions to Biomea Fusion could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Biomea Fusion when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Biomea Fusion - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Biomea Fusion to buy it.
The correlation of Biomea Fusion is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Biomea Fusion moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Biomea Fusion moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Biomea Fusion can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Biomea Fusion Piotroski F Score and Biomea Fusion Altman Z Score analysis. For information on how to trade Biomea Stock refer to our How to Trade Biomea Stock guide. Note that the Biomea Fusion information on this page should be used as a complementary analysis to other Biomea Fusion's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.

Complementary Tools for Biomea Stock analysis

When running Biomea Fusion price analysis, check to measure Biomea Fusion's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biomea Fusion is operating at the current time. Most of Biomea Fusion's value examination focuses on studying past and present price action to predict the probability of Biomea Fusion's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Biomea Fusion's price. Additionally, you may evaluate how the addition of Biomea Fusion to your portfolios can decrease your overall portfolio volatility.
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Is Biomea Fusion's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biomea Fusion. If investors know Biomea will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biomea Fusion listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
Return On Assets
Return On Equity
The market value of Biomea Fusion is measured differently than its book value, which is the value of Biomea that is recorded on the company's balance sheet. Investors also form their own opinion of Biomea Fusion's value that differs from its market value or its book value, called intrinsic value, which is Biomea Fusion's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biomea Fusion's market value can be influenced by many factors that don't directly affect Biomea Fusion's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biomea Fusion's value and its price as these two are different measures arrived at by different means. Investors typically determine Biomea Fusion value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biomea Fusion's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.